Literature DB >> 19508320

Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin.

M Andreucci1, G Fuiano, P Presta, G Lucisano, F Leone, L Fuiano, V Bisesti, P Esposito, D Russo, B Memoli, T Faga, A Michael.   

Abstract

OBJECTIVE: Erythropoietin has been shown to have a protective effect in certain models of ischaemia-reperfusion, and in some cases the protection has been correlated with activation of signalling pathways known to play a role in cell survival and proliferation. We have studied whether erythropoietin would overcome direct toxic effects of hydrogen peroxide (H(2)O(2)) treatment to human renal proximal tubular (HK-2) cells.
MATERIALS AND METHODS: HK-2 cells were incubated with H(2)O(2) (2 mm) for 2 h with or without erythropoietin at concentrations of 100 and 400 U/ml, and cell viability/proliferation was assessed by chemical reduction of MTT. Changes in phosphorylation state of the kinases Akt, glycogen synthase kinase-3beta (GSK-3beta), mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase 1 and 2 (ERK1/ERK2) were also analysed.
RESULTS: Cells incubated with H(2)O(2) alone showed a significant decrease in viability, which did not significantly change by addition of erythropoietin at concentration of 100 U/ml, but was further reduced when concentration of erythropoietin was increased to 400 U/ml. Phosphorylation state of the kinases Akt, GSK-3beta, mTOR and ERK1/ERK2 of H(2)O(2)-treated HK-2 cells was slightly altered in the presence of erythropoietin at concentration of 100 U/ml, but was significantly less in the presence of erythropoietin at a concentration of 400 U/ml. Phosphorylation of forkhead transcription factor FKHRL1 was diminished in cells incubated with H(2)O(2) and erythropoietin at a concentration of 400 U/ml.
CONCLUSIONS: Erythropoietin, at high concentrations, may significantly increase cellular damage in HK-2 cells subjected to oxidative stress, which may be due in part to decrease in activation of important signalling pathways involved in cell survival and/or cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508320      PMCID: PMC6496929          DOI: 10.1111/j.1365-2184.2009.00617.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  45 in total

Review 1.  Hyporesponsiveness to recombinant human erythropoietin.

Authors:  T Drüeke
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

2.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

Review 3.  The role of oxygen radical-mediated signaling pathways in endometrial function.

Authors:  N Sugino
Journal:  Placenta       Date:  2007-02-08       Impact factor: 3.481

4.  Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells.

Authors:  Istvan Arany; Judit K Megyesi; Hideaki Kaneto; Sakae Tanaka; Robert L Safirstein
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

5.  Erythropoietin receptor mRNA expression in human endothelial cells.

Authors:  A Anagnostou; Z Liu; M Steiner; K Chin; E S Lee; N Kessimian; C T Noguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Erythropoietin protects against ischaemic acute renal injury.

Authors:  David A Vesey; Catherine Cheung; Betty Pat; Zoltan Endre; Glenda Gobé; David W Johnson
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

Review 7.  Postischemic renal injury due to oxygen radicals.

Authors:  K J Johnson; J M Weinberg
Journal:  Curr Opin Nephrol Hypertens       Date:  1993-07       Impact factor: 2.894

Review 8.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 9.  Free radical-mediated postischemic injury in renal transplantation.

Authors:  M S Paller
Journal:  Ren Fail       Date:  1992       Impact factor: 2.606

Review 10.  Pleiotropic functions of erythropoietin.

Authors:  Ryuzo Sasaki
Journal:  Intern Med       Date:  2003-02       Impact factor: 1.271

View more
  28 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

Review 2.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 3.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

Review 4.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 5.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

6.  Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress.

Authors:  Chad Brocker; Natalie Lassen; Tia Estey; Aglaia Pappa; Miriam Cantore; Valeria V Orlova; Triantafyllos Chavakis; Kathryn L Kavanagh; Udo Oppermann; Vasilis Vasiliou
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 7.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

Review 8.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

Review 9.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

Review 10.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.